Open Access

[Retracted] MEG‑3‑mediated Wnt/β‑catenin signaling pathway controls the inhibition of tunicamycin‑mediated viability in glioblastoma

  • Authors:
    • Xiangyu Cui
    • Dezhou Sun
    • Bin Shen
    • Xin Wang
  • View Affiliations

  • Published online on: June 30, 2025     https://doi.org/10.3892/ol.2025.15162
  • Article Number: 416
  • Copyright : © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

September-2025
Volume 30 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cui X, Sun D, Shen B and Wang X: [Retracted] MEG‑3‑mediated Wnt/β‑catenin signaling pathway controls the inhibition of tunicamycin‑mediated viability in glioblastoma. Oncol Lett 30: 416, 2025.
APA
Cui, X., Sun, D., Shen, B., & Wang, X. (2025). [Retracted] MEG‑3‑mediated Wnt/β‑catenin signaling pathway controls the inhibition of tunicamycin‑mediated viability in glioblastoma. Oncology Letters, 30, 416. https://doi.org/10.3892/ol.2025.15162
MLA
Cui, X., Sun, D., Shen, B., Wang, X."[Retracted] MEG‑3‑mediated Wnt/β‑catenin signaling pathway controls the inhibition of tunicamycin‑mediated viability in glioblastoma". Oncology Letters 30.3 (2025): 416.
Chicago
Cui, X., Sun, D., Shen, B., Wang, X."[Retracted] MEG‑3‑mediated Wnt/β‑catenin signaling pathway controls the inhibition of tunicamycin‑mediated viability in glioblastoma". Oncology Letters 30, no. 3 (2025): 416. https://doi.org/10.3892/ol.2025.15162